UPCOMING EVENTS: AAOS - March 14-18 | BASK - March 14-18 | BBA - May 4-6 | EWMA - May 4-6
Avomed operate in market segments with a 2020 predicted market size of over $160 billion.
Sports medicine involves the treatment and prevention of injuries related to sports and exercise. Products are used by both athletes and non-athletes and include body reconstruction and repair products, body support and recovery products, and accessories.
Based on application, the market is segmented into knee injuries, shoulder injuries, ankle and foot injuries, elbow and wrist injuries, hip and groin injuries, back and spine injuries, and other injuries. In 2015, the knee injuries segment is estimated to account for the major share of the sports medicine market.
The global sports medicine market is expected to reach USD 8.3 Billion by 2020 from USD 5.6 Billion in 2015, at a CAGR of 8.0%.
The Global Orthopaedics Implants Market is poised to grow at a CAGR of around 8.8% over the next decade to reach approximately $91.42 billion by 2025. Some of the prominent trends that the market is witnessing include increasing geriatric population, increasing healthcare awareness, technological developments of orthopaedic implants and growth opportunities/investment opportunities.
Based on application, the market is classified into dental orthopaedic implants, spine orthopaedic implants, hip orthopaedic implants, foot and ankle, knee orthopaedic implants, trauma and extremities, craniomaxillofacial orthopaedic implants and S.E.T (sports medicine, extremities, trauma) orthopaedic implants.
The global bio surgery market should reach $8.3 billion and $12.5 billion in 2016 and 2021, respectively, growing at a five-year compound annual growth rate (CAGR) of 8.5%. The North American market should total $4.7 billion by 2021, up from $3.4 billion in 2016, demonstrating a five-year CAGR of 6.9%. The Asia-Pacific market should grow from $1.7 billion in 2016 to $3.0 billion by 2021 at a five-year CAGR of 11.1%.
The bio surgery products utilized globally in different surgical operations can be classified into anti-adhesive agents, haemostatic agents, surgical sealing agents, bone-graft substitutes, and soft tissue-management products, along with surgical synthetic and biological meshes. Among all products, bone-graft substitutes generate the most revenue, accounting for about $2.6 billion in 2015. This segment is expected to total $3.7 billion by 2021, growing at a five-year CAGR of 6.1% from 2016 to 2021. Surgical sealants products is projected as the fastest-growing segment among all markets with a five-year CAGR of 11% from 2016 to 2021, followed by the anti-adhesive agent segment with a five-year CAGR of 10.9%.
The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%. The global market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2016.
Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market.
This market is also segmented by application. By application, the segments are orthopaedic and musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing application market in the global market in 2016.
The Advanced Wound Care Market is expected to reach USD 14.9 billion by 2020 and is estimated to grow at a CAGR of 7.0% from 2015 to 2020.
Advanced wound care products are used when the standard wound care treatment fails. Treatment in advanced wound care involves interventions therapies and products, such as collagen products, NPTW antimicrobial dressings, foam dressings, gauze, hydrocolloids, film dressings, hydrogels, composites, and alginate dressings, among others.
Geographically, the North America advanced wound care market contributed 34.4%market share in 2014. The European market was valued at USD 3.2 billion in 2014, and is expected to grow at a CAGR of 6.8% from 2015 to 2020. In terms of high growth potential, the U.K. advanced wound care market is an open market, expected to witness growth at the fastest rate from 2015 to 2020.
The global advanced wound care market is expected to grow due to the rising aging population, growing incidences of diabetes, and technological advancements. However, the high cost of advanced wound care products act as a major restraining factor.
